
Buy PE-22-28 Research Peptide
Supplied as a lyophilized powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.

Buy PE-22-28 Research Peptide
Supplied as a lyophilized powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Available
Every batch
Ships Next Day
Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Available
Every batch
Ships Next Day
Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.
Verify Batch
Lot-level COA, Batch DF/PE2/062026
What is PE-22-28?
PE-22-28 is a synthetic version of spadin, a natural fragment involved in regulating a specific potassium channel (TREK-1) in the brain. It is studied in animal research as a tool for looking at this channel and related brain signaling.
- A synthetic analog of spadin, a natural fragment that regulates the TREK-1 channel
- Studied in animal research as a tool for TREK-1 potassium-channel signaling
- Studied in animal models of depression-like behaviour, a context in which TREK-1 blockade has been linked to serotonergic neurotransmission — an effect demonstrated for TREK-1-deficient mice and for the parent peptide spadin rather than measured directly for PE-22-28
- Studied for its effects on new brain-cell growth and brain-cell connections
For research use only. Not approved for human therapeutic use.
PE-22-28 is a synthetic heptapeptide analog of Spadin with an approximate molecular weight of 773.89 g/mol. It is derived from the 44-amino acid propeptide (PE) of the sortilin receptor and corresponds to a truncated fragment of the 17-amino acid peptide Spadin (PE 12-28), retaining the minimal sequence associated with modulation of the TWIK-related potassium channel-1 (TREK-1). TREK-1 is a two-pore domain potassium channel (K2P2.1) expressed throughout the central nervous system and implicated in the regulation of neuronal excitability. Produced via solid-phase peptide synthesis, PE-22-28 is associated with TREK-1 channel modulation and monoaminergic signaling pathways.
PE-22-28 has been investigated in preclinical neuropharmacology as a minimal-length TREK-1 channel modulator and was developed as a shorter, more metabolically tractable analog retaining the active pharmacophore. In vitro electrophysiology studies have documented that PE-22-28 inhibits TREK-1 currents recorded by whole-cell patch clamp in a TREK-1-expressing HEK cell line, blocking the arachidonic-acid-activated channel with markedly greater potency than the parent peptide, and have characterized it as the shortest Spadin-derived fragment retaining TREK-1 inhibitory activity [1]. In vivo rodent studies have examined the compound in behavioral pharmacology paradigms, documenting that PE-22-28 produced antidepressant-like effects in the forced swim, novelty-suppressed feeding and learned-helplessness paradigms and in a corticosterone-induced depression model, and that a four-day systemic (ip) administration schedule increased hippocampal neurogenesis in vivo, while direct application of PE-22-28 to cultured mouse cortical neurons increased the synaptogenesis marker PSD-95 in vitro [1][2], making PE-22-28 a reference compound in preclinical neuropharmacology research examining Spadin-derived TREK-1 channel modulation and hippocampal neuroplasticity in rodent models.
PE-22-28 is produced to research-grade standards and independently verified by third-party HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available to view and download directly on the product page.
Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.
References
Scientific Review

Dr. Martina Rossi, PhD
Scientific Contributor and Reviewer
Reviewed for scientific accuracy, 11 August 2026
Lyophilised powder: store at -20 °C or below, away from light and moisture. Once reconstituted in an appropriate laboratory diluent (e.g. sterile water, PBS, or assay buffer), store at 2–8 °C and use within the validated period for your protocol. Do not refreeze.
What Researchers Say
Sign in to leave a reviewNo reviews yet. Be the first to share your research experience.
Frequently Asked Questions
Select Size
Quality Guaranteed
Every batch is HPLC-tested to ≥98% purity. Certificate of Analysis available on this page; MSDS available on request.






